KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Astrana Health (ASTH) over the last 17 years, with Q3 2025 value amounting to $648.5 million.

  • Astrana Health's Cash from Financing Activities rose 2042887.15% to $648.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $580.4 million, marking a year-over-year increase of 25738.58%. This contributed to the annual value of $135.1 million for FY2024, which is 385048.23% up from last year.
  • Latest data reveals that Astrana Health reported Cash from Financing Activities of $648.5 million as of Q3 2025, which was up 2042887.15% from -$8.6 million recorded in Q2 2025.
  • In the past 5 years, Astrana Health's Cash from Financing Activities registered a high of $648.5 million during Q3 2025, and its lowest value of -$44.2 million during Q1 2025.
  • In the last 5 years, Astrana Health's Cash from Financing Activities had a median value of -$963000.0 in 2023 and averaged $35.1 million.
  • As far as peak fluctuations go, Astrana Health's Cash from Financing Activities crashed by 143439.85% in 2023, and later skyrocketed by 2042887.15% in 2025.
  • Over the past 5 years, Astrana Health's Cash from Financing Activities (Quarter) stood at $1.4 million in 2021, then soared by 309.13% to $5.9 million in 2022, then skyrocketed by 104.28% to $12.0 million in 2023, then crashed by 227.3% to -$15.3 million in 2024, then skyrocketed by 4347.66% to $648.5 million in 2025.
  • Its Cash from Financing Activities was $648.5 million in Q3 2025, compared to -$8.6 million in Q2 2025 and -$44.2 million in Q1 2025.